Key result
Routine preoperative testing recommendations have decreased due to a lack of evidence for prophylactic revascularization, though identifying patients at high cardiovascular risk remains fundamental.
Answers are grounded in this paper and cite their sources.
Discusses the role and challenges of using coronary CTA for preoperative cardiovascular risk stratification.
More than 300 million surgeries are performed annually worldwide. Despite improvements in surgical techniques and anaesthesia, mortality related to these procedures is still higher than expected. Since cardiovascular complications are important contributors to postoperative morbidity and mortality, it is fundamental to identify patients at increased cardiovascular risk, not only to take measures to decrease risk but also to access the risk–benefit ratio of the surgery. Although the core of preoperative risk stratification are clinical risk scores, such as the Revised Cardiac Risk Index, they are known to have limited accuracy and additional tools to improve risk assessment may be needed for part of the population. Among the various cardiovascular complications commonly seen in the perioperative period, myocardial infarction/injury (PMI) are important contributors to mortality. Although in other clinical scenarios most of those episodes are mostly related to coronary plaque rupture or other acute atherosclerotic plaque instability defining a type 1 myocardial infarction (MI), in the perioperative period a significant proportion of events are also caused by oxygen supply demand mismatch, known as type 2 MI, though this is also most common in individuals with prior coronary artery disease (CAD).1 2 Despite the need to identify higher risk individuals, recommendations for routine preoperative testing have substantially decreased in the last two decades.3 This was motivated by the negative results of several randomised trials evaluating preoperative ‘prophylactic’ myocardial revascularisation, that failed to show benefit,4 5 as well as by the lack of evidence that performing preoperative testing reduces postoperative cardiac complications. In fact, unnecessary preoperative testing could result in harm by delaying surgery and compromising the prognosis of the disease leading to the indication for surgery. Yet, despite those restrictions, higher risk …
No takes yet. Share an insight, caveat, or question.
Bittencourt et al. (2019) conducted an editorial in Preoperative cardiovascular risk. Coronary CTA was evaluated. Routine preoperative testing recommendations have decreased due to a lack of evidence for prophylactic revascularization, though identifying patients at high cardiovascular risk remains fundamental.
Synapse has enriched 10 related papers. Consider them for comparative context: